Peripheral blood smear from a patient with known chronic lymphocytic leukemia (CLL) showing autoimmune hemolytic anemia (AIHA). Brightfield microscopy of Wright-Giemsa stained smear at 1000x (oil immersion) reveals two dominant cell populations: numerous small mature lymphocytes typical of CLL and red blood cells showing spherocytic deformation. A smudge cell is evident just left of center, a classical clue for CLL. Red cells display reduced central pallor consistent with spherocytes, indicating intravascular or extravascular hemolysis driven by autoantibodies. The background shows mild polychromasia and rare nucleated RBCs, consistent with a robust reticulocyte response; the corrected reticulocyte count in this case is markedly elevated (>7%). Platelets are not significantly abnormal. These features collectively support autoimmune destruction of erythrocytes in the setting of CLL. Diagnostic significance lies in recognizing AIHA as a common autoimmune complication in CLL, with a clinical picture of sudden Hb decline and compensatory erythropoiesis. Differential considerations include drug-induced hemolysis, other causes of hemolytic anemia, or marrow infiltration by CLL. Clinical correlation includes therapy implications (steroids, rituximab) and close monitoring of hemolysis markers. This image is a valuable teaching resource for hematology morphology, AIHA in CLL, and differential diagnosis in anemia.

This composite image consists of clinical photographs and a diagnostic peripheral blood smear. Figure 1a (left) shows a pediatric patient with clinical signs including total alopecia (complete absence of scalp hair) and nail pitting affecting both hands and feet, characterized by small punctate depressions on the nail plates. Figure 1b (right) is a microscopic view of a peripheral blood smear demonstrating microangiopathic hemolytic anemia. Visible are numerous schistocytes—fragmented, irregular red blood cells including helmet cells and triangular forms—alongside some normal erythrocytes showing central pallor. The educational focus is on the multi-systemic manifestations of a medical condition, likely a microangiopathic process such as Hemolytic Uremic Syndrome (HUS) or similar systemic pathology, illustrating the correlation between dermatological signs (hair and nail changes) and hematological abnormalities (hemolysis and schistocytosis).

Comprehensive description: Brightfield light microscopy image of a peripheral blood smear stained with Wright-Giemsa, captured at high magnification to visualize circulating plasma cells. The central plasmablast shows an enlarged, irregular nucleus with a prominent nucleolus; the cytoplasm is moderately basophilic. This cell appears larger than surrounding erythrocytes and is consistent with malignant plasma cells typical of plasma cell leukemia. The background demonstrates rouleaux formation of red blood cells, a common feature in paraproteinemias due to increased serum proteins. The smear illustrates plasmacytosis that, when exceeding 20% of leukocytes, supports a diagnosis of plasma cell leukemia. In PCL, neoplastic plasma cells may be CD56 negative and often secrete monoclonal immunoglobulin with IgD or IgE isotypes or light-chain restriction; cytogenetic abnormalities are frequently observed. Morphology alone cannot definitively distinguish PCL from aggressive myeloma; immunophenotyping and cytogenetic studies are essential for precise classification. This image is valuable for hematology education, cytology review, and discussions of malignant plasma cell disorders, including primary versus secondary PCL, and their prognostic significance. Potential clinical utilities include morphologic confirmation in suspected PCL, training in recognition of plasmablasts, and correlation with CBC abnormalities and clinical features such as anemia, thrombocytopenia, lymphadenopathy, and organomegaly.

Peripheral blood smear prepared with Wright-Giemsa stain and examined under brightfield illumination using a 100× oil immersion objective reveals a single large plasma cell among a field of mature erythrocytes. The plasma cell displays features typical of clonal plasma cells: basophilic cytoplasm, an eccentrically placed round nucleus, and a conspicuous perinuclear hof; background shows rouleaux formation of red cells. This image exemplifies hematologic involvement by a plasma cell dyscrasia. In plasma cell leukemia, circulating plasma cells constitute more than 20% of leukocytes, a hallmark distinguishing it from conventional multiple myeloma, although both conditions share monoclonal plasma cell proliferation. The presence of circulating plasma cells is associated with younger patient age, higher incidence of anemia, thrombocytopenia, organomegaly, and possible lymphadenopathy; however lytic bone lesions may be less common. Immunophenotypic patterns often include lack of CD56 expression relative to myeloma. Clinically, this morphological finding warrants confirmation with complete blood count, peripheral smear review, quantitative plasma cell percentage, serum protein electrophoresis, and immunofixation to identify monoclonal immunoglobulin isotype (IgD/IgE or light-chain predominance). Early detection of circulating plasma cells supports prognosis assessment and guides therapy decisions in plasma cell dyscrasia management and monitoring, including risk stratification and treatment response evaluation for practice in clinics.

This peripheral blood smear was prepared and stained with Wright-Giemsa and examined by bright-field light microscopy to assess circulating hematopoietic cells in suspected systemic mastocytosis (SM). The smear shows rare, but conspicuous, mast cells with round to polygonal shapes and abundant cytoplasmic granules that impart a deep purple, metachromatic appearance. Nuclei are generally round to ovoid and may be slightly irregular or bilobed in some cells; granules occupy most of the cytoplasm and may obscure nuclear detail. The surrounding leukocytes include eosinophils and neutrophils, and the erythrocyte background is normocytic with occasional anisocytosis. In SM, circulating mast cells are typically infrequent; when they constitute a substantial fraction of leukocytes (≥10%), the finding is highly suggestive of mast cell leukemia (MCL). The image exemplifies an increased mast cell burden consistent with aggressive SM or MCL, often accompanied by cytopenias such as anemia or thrombocytopenia and potential associated hematologic neoplasms (e.g., CMML, MDS/MPN). This morphologic snapshot supports integration with phenotypic assays (CD117/c-KIT), flow cytometry, and molecular testing for KIT mutations, to establish diagnosis, prognostication, and therapeutic planning. Relevant keywords: systemic mastocytosis, mast cell leukemia, circulating mast cells, metachromatic granules, Wright-Giemsa, toluidine blue, KIT D816V, CD117, SM-AHN. This description emphasizes morphology guiding diagnosis appropriately.

Imaging Modality: Brightfield light microscopy of a Wright-Giemsa stained peripheral blood smear. The primary subject is leukocytes from circulating blood, with focus on small mature-appearing lymphocytes and rare prolymphocytes. At center-right, several lymphocytes exhibit condensed chromatin and scant cytoplasm, consistent with chronic lymphocytic leukemia (CLL) morphology. Along the left edge, characteristic smudge cells are visible, reflecting fragile lymphocytes commonly seen in CLL. A prolymphocyte located just below center presents with slightly irregular nuclear contours, more dispersed chromatin, a prominent nucleolus, and modestly increased cytoplasm. In CLL, prolymphocytes usually comprise less than 2% of neoplastic cells; when 10–15%, the term atypical CLL is used and carries implications of aberrant immunophenotype, cytogenetic abnormalities, cytopenias, refractoriness to therapy, and worse prognosis. If prolymphocytes predominate, consideration should be given to B-cell prolymphocytic leukemia. This image demonstrates key diagnostic features including lymphoid morphology, prolymphocytic variant, and smear artifacts. Clinically, these findings correlate with lymphocytosis and potential anemia or thrombocytopenia in affected patients. Definitive characterization requires ancillary testing such as flow cytometry, immunophenotyping, and cytogenetics. The morphology supports a differential diagnosis that includes CLL with prolymphocytic transformation, atypical CLL, and B-PLL, guiding prognosis and treatment planning.

A comparative medical illustration detailing the effects of iron dysregulation on wound healing and systemic states. The left panel depicts a 'Low Iron' and 'Inflammation' scenario where a cutaneous wound is associated with 'Iron-deficiency anemia'. Key signaling molecules shown include TGF, IL-6, IL-8, and ECM components within a wound bed containing fibroblasts and matrix elements. An arrow indicates the downstream impact on the underlying epithelium and hemoglobin within the bloodstream. The right panel depicts an 'Excessive Iron' and 'Skin damage' scenario characterized by 'Excessive iron deposition'. This state is visually distinguished by an inhibitory symbol (red T-bar) directed at the epithelium, suggesting impaired regenerative capacity. Notably, the epithelium in the high-iron state contains yellow granules labeled as 'Iron-containing haematoxylin' (hemosiderin), which serve as a histological marker of iron overload. Both panels show the anatomical relationship between the cutaneous wound, underlying epithelial cells, and the intravascular space (bloodstream) containing red blood cells and hemoglobin, illustrating how iron homeostasis is critical for normal dermatological repair and systemic oxygen transport.

This composite clinical photograph illustrates common physical examination findings associated with severe anemia. The left panel shows the bilateral palms of a patient, demonstrating marked palmar pallor. The skin on the palms and creases appears significantly lighter and lacks the typical pinkish hue of healthy vascularized tissue, suggesting reduced hemoglobin concentration. The right panel is a close-up of the patient's face with the lower eyelid retracted to reveal the palpebral conjunctiva. Instead of the normal vibrant red or pink color, the conjunctiva exhibits conjunctival pallor, appearing whitish or very pale pink. These visual signs are critical diagnostic markers in hematology and general medicine for identifying systemic conditions such as iron-deficiency anemia or other forms of chronic blood loss. The image serves as a teaching tool for medical students and clinicians to recognize mucosal and cutaneous indicators of decreased red blood cell mass or oxygen-carrying capacity.

Educational figure illustrating hematological abnormalities in a murine model of Prkab1 deficiency, serving as a surrogate for studying human hemolytic anemia and microcytosis. Panels A-F present dot plots of hematological indices for wild-type (Prkab1+/+) and deficient (Prkab1tm1b/tm1b) mice, showing significant reductions in hemoglobin (A), hematocrit (B), and mean corpuscular volume (E), with a concomitant increase in red blood cell distribution width (F), indicating microcytic anemia with anisocytosis. Panel G contains high-resolution Scanning Electron Microscopy (SEM) images comparing erythrocyte morphology; wild-type cells show standard biconcave discocyte morphology, whereas Prkab1-deficient cells exhibit poikilocytosis with numerous abnormal forms, including acanthocytes, schistocytes, and echinocytes with irregular surface protrusions. Panel H displays an osmotic resistance curve, where Prkab1-deficient erythrocytes demonstrate a left-ward shift, signifying increased osmotic resistance (delayed hemolysis) compared to wild-type controls. The inset confirms a lower NaCl percentage required for 50% hemolysis in deficient cells, indicating altered membrane stability.

A multi-panel medical illustration and data graphic comparing normal hemoglobin and sickle cell disease (SCD) hemoglobin. (a) A 3D schematic of a bifurcating blood vessel showing the movement of red blood cells. (b, c) Magnified views contrasting the flexible, biconcave disc morphology of normal hemoglobin with the rigid, elongated, crescent or sickle shape characteristic of SCD hemoglobin, illustrating the mechanism for vascular occlusion. (d, e) Ball-and-stick molecular models detailing Heme (with Fe2+) and Sickle Heme (associated with Fe3+), emphasizing structural differences at the molecular level. (f) A comparative fluorescence spectrum plot showing Protoporphyrin (black), Sickle-cell Disease Hemoglobin (red), and Normal Hemoglobin (blue) across wavelengths of 610–690 nm. The graph highlights diagnostic spectral shifts: Protoporphyrin peaks at ~628.1 nm, while hemoglobin variants show distinctive primary peaks at ~672.5 nm and secondary peaks showing shifts (629.5 nm for normal vs. 633.8 nm for sickle). This composite image serves to correlate clinical hematology, cellular morphology, and molecular spectroscopy in the study of Sickle Cell Anemia.

This clinical photograph displays a comparative gross pathological examination of human placentas categorized by maternal hemoglobin genotype: sickle cell anemia (HbSS), sickle cell hemoglobin C disease (HbSC), and normal adult hemoglobin (HbAA/Control). The image is arranged in a grid showing both fetal sides (left column: A, C, E) and maternal sides (right column: B, D, F). Panels A and B (HbSS): The fetal side shows prominent, congested vasculature and subchorionic fibrin deposition. The maternal side exhibits a deep, dusky red color with a rough, nodular texture. Panels C and D (HbSC): These display significant gross abnormalities, including extensive yellowish-white plaques of subchorionic fibrin deposition covering approximately 50% of the fetal surface. The maternal side shows lighter, gritty areas indicative of calcifications. Panels E and F (HbAA): The control placenta shows a healthy, glistening fetal surface with distinct, regular branching vessels and a uniform, dark red maternal surface with smooth cotyledons. This comparison illustrates placental manifestations of Sickle Cell Disease (SCD), highlighting pathological changes such as increased fibrin deposition and calcification associated with maternal hematological conditions.

Microscopic analysis of a human red blood cell (RBC) infected with Plasmodium falciparum at the schizont stage. The image presents a 3x3 grid comparing brightfield images (a–c), reconstructed 3D refractive index (RI) distributions (d–f), and hemoglobin content maps (g–i) across three z-planes (z = 0.2 μm, 0 μm, and -0.2 μm). The brightfield images show a distorted cell morphology consistent with advanced parasitic infection. The refractive index maps (d–f) utilize a color scale from 1.34 to 1.44; high RI focal points (yellow-red, RI > 1.42) identify localized hemozoin crystals, the byproduct of hemoglobin digestion. The hemoglobin content maps (g–i) use a quantitative color scale from 0 to 45 g/dL, highlighting asymmetric, depleted hemoglobin distribution (red-to-yellow) compared to healthy RBCs. Spatial variations across the z-planes demonstrate the heterogeneous internal structure of the parasitized cell, including the presence of multiple merozoites and metabolic waste within the host cytoplasm. This visualization is used in hematology and infectious disease research to quantify biochemical and morphological changes during the intra-erythrocytic cycle of malaria.

This diagnostic image is a low-magnification light microscopy photomicrograph of a bone marrow trephine biopsy, likely stained with hematoxylin and eosin (H&E). The specimen exhibits marked hypocellularity, a hallmark of severe aplastic anemia. The hematopoietic space is predominantly occupied by clear, vacuolated adipocytes (fatty marrow), with a notable absence of normal myeloid, erythroid, and megakaryocytic cell lines. Eosinophilic (pink) trabecular bone spicules are visible at the periphery and interspersed within the marrow cavity, providing structural context. The clinical significance of this finding is the demonstration of bone marrow failure, where the functional marrow has been replaced by adipose tissue. The absence of infiltrative abnormal cells or significant fibrosis is a key negative finding for differentiating this from myelodysplastic syndromes or myelofibrosis.

A multi-modal comparison of bone marrow characteristics between Aplastic Anemia (AA) and Myelodysplastic Syndromes (MDS). Panels A, B, D, and E show axial magnetic resonance (MR) images of the pelvis at the level of the left posterior superior ilium. Panels A and D are fat fraction (FF) maps, where the ROI in AA (A) displays significantly higher signal hyperintensity (86.98% FF) compared to MDS (D, 25.84% FF), indicating extensive fatty replacement of marrow. Panels B and E represent R2* maps used for iron content quantification (117.91 vs 147.98/second). Panels C and F provide corresponding H&E stained histological sections of the bone marrow. The AA section (C) demonstrates hypocellularity with a marked increase in large, clear adipocytes (black arrow) and sparse hematopoietic cells. In contrast, the MDS section (F) shows hypercellular marrow with higher hematopoietic cell density and fewer adipocytes (black arrow) amidst bone trabeculae. This composite image illustrates the clinical application of IDEAL-IQ MRI sequences in differentiating marrow failure syndromes by correlating quantitative imaging metrics with histopathological findings.

This medical illustration depicts the four primary stages of the neutrophil lifecycle using a linear progression diagram. Starting from the left, the first stage is 'Granulopoiesis within the bone marrow,' represented by an illustration of a long bone where neutrophil production occurs. An arrow leads to the second stage, 'Release into systemic circulation,' symbolized by an anatomical heart with branching vasculature. The third stage, 'Extravasation through the endothelium,' displays a detailed cross-sectional view of a postcapillary venule, showing the endothelial lining and the process of leukocytes exiting the vessel into the interstitium. The final stage on the right, 'Migration and immune response within inflammatory tissues of the human body,' illustrates various target organs, including the lungs, liver, and intestines, where neutrophils perform innate immune functions such as phagocytosis and chemotaxis. The illustration serves as an educational summary of hematopoiesis, vascular transit, and the localized inflammatory response.